Case Report: Efgartigimod: a beacon of hope for overlapping stiff-person syndrome and myasthenia gravis following thymoma - Top-Institutions - MDSpire

Clinical Case Study: Efgartigimod as a Promising Treatment for Concurrent Stiff-Person Syndrome and Myasthenia Gravis Associated with Thymoma

  • By

  • Jingjing Nie

  • Weifan Yin

  • July 20, 2026

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    UCSF Health (University of California, San Francisco)
    UCSF Health (University of California, San Francisco)

    San Francisco, California

    Key Differentiators

    • Neurology
    • Neuroimmunology

  • #2

    Cleveland Clinic Neurological Institute
    Cleveland Clinic Neurological Institute

    Cleveland, Ohio

    Key Differentiators

    • Neurology
    • Neuroimmunology

  • #3

    Peking Union Medical College Hospital
    Peking Union Medical College Hospital

    Beijing, China

    Key Differentiators

    • Neurology

  • #4

    Policlinico A. Gemelli
    Policlinico A. Gemelli

    Rome, Italy

    Key Differentiators

    • Neurology

  • #5

    Azienda Ospedaliera Sant’Andrea
    Azienda Ospedaliera Sant’Andrea

    Rome, Italy

    Key Differentiators

    • Neurology

Original Source(s)

Case Report: Efgartigimod: a beacon of hope for overlapping stiff-person syndrome and myasthenia gravis following thymoma

  • by Jingjing Nie, Weifan Yin

  • July 20, 2026

Related Content

Sedative medications: a potentially modifiable risk factor for improving neurocognitive outcomes after critical illness in infants and children

Complement dysregulation during the early phases of synucleinopathy

The non-linear association between preoperative platelet to white blood cell ratio and 30-day postoperative mortality in adult tumor craniotomy: a retrospective cohort study